2019
DOI: 10.1590/1678-4685-gmb-2018-0033
|View full text |Cite
|
Sign up to set email alerts
|

De novo transcriptome analysis of Tibetan medicinal plant Dysphania schraderiana

Abstract: Dysphania schraderiana is widely distributed in Lhasa (Tibet, China) and used as a traditional medicine. However, the lack of genetic information hinders the understanding of its physiological processes, such as the biosynthesis of secondary metabolites. Herein, we used Illumina Hiseq4000 platform to sequence the transcriptome of flower and leaf tissues from D. schraderiana for the first time. Totally, 40,142 unigenes were assembled from approximately 5.2 million clean reads. … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 8 publications
(2 citation statements)
references
References 33 publications
(35 reference statements)
0
2
0
Order By: Relevance
“…With the development and implementation of advanced DNA sequencing technologies, the biological metabolisms of active components may be discerned in medicinal plants (Fu et al, 2019;Liang et al, 2019;Niazian, 2019). There are few studies on the biosynthesis of polysaccharides (this research has focused primarily on fungal species) due to their unique structures and large molecular weights (Ribeiro et al, 2012;Zhang et al, 2019b).…”
Section: Introductionmentioning
confidence: 99%
“…With the development and implementation of advanced DNA sequencing technologies, the biological metabolisms of active components may be discerned in medicinal plants (Fu et al, 2019;Liang et al, 2019;Niazian, 2019). There are few studies on the biosynthesis of polysaccharides (this research has focused primarily on fungal species) due to their unique structures and large molecular weights (Ribeiro et al, 2012;Zhang et al, 2019b).…”
Section: Introductionmentioning
confidence: 99%
“…Further, differential expression analysis between the corm, leaf and flower provides a reduced set of uncharacterised genes that narrows down the list of genes possibly imparting medicinal properties to the corm. Cross-tissue transcriptomic analyses have been performed in the past to identify candidate genes involved in the biosynthesis of secondary metabolites in medicinal plants like Ferula asafoetida, Dysphania schraderiana and Salvia miltiorrhiza [21][22][23]. In this study, aside from transcriptomic analyses, proteomic profiling was performed on the flower, leaf and corm tissues from Hypoxis hemerocallidea.…”
Section: Introductionmentioning
confidence: 99%